AMETEK (NYSE:AME) is scheduled to be announcing its earnings results before the market opens on Tuesday, July 30th. Analysts expect the company to announce earnings of $1.03 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

AMETEK (NYSE:AME) last issued its quarterly earnings data on Wednesday, May 1st. The technology company reported $1.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.03. The company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.28 billion. AMETEK had a net margin of 16.14% and a return on equity of 18.56%. The company’s revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.79 earnings per share. On average, analysts expect AMETEK to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Shares of AME opened at $89.28 on Monday. The company has a market capitalization of $20.34 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 2.28 and a beta of 1.24. The company has a 50-day moving average of $88.69. AMETEK has a fifty-two week low of $63.14 and a fifty-two week high of $92.30. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.91 and a quick ratio of 1.27.

In other AMETEK news, VP Thomas M. Montgomery sold 5,602 shares of the firm’s stock in a transaction dated Thursday, June 27th. The shares were sold at an average price of $88.50, for a total value of $495,777.00. Following the transaction, the vice president now directly owns 26,419 shares of the company’s stock, valued at approximately $2,338,081.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Anthony James Conti sold 1,570 shares of the firm’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $87.79, for a total transaction of $137,830.30. Following the completion of the transaction, the director now directly owns 17,198 shares in the company, valued at $1,509,812.42. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 93,370 shares of company stock worth $8,072,702. 0.80% of the stock is owned by insiders.

Several equities analysts have recently weighed in on AME shares. BMO Capital Markets raised shares of TMAC Resources from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 2nd. KeyCorp reaffirmed a “hold” rating on shares of Ball in a research report on Thursday, May 2nd. ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. Zacks Investment Research lowered shares of Essential Properties Realty Trust from a “buy” rating to a “hold” rating in a research report on Thursday, June 13th. Finally, Vertical Research reaffirmed a “buy” rating on shares of AMETEK in a research report on Friday, May 3rd. Fifteen equities research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $91.50.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

See Also: How a Strangle Strategy is different from a Straddle Strategy

Earnings History for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.